Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I was told by someone way smarter than me (which according to some posters here is quite a few, LOL) that it is a good sign that they paid for the patent either today or yesterday. This person told me that it likely means that this version of Flaskworks has completed the compatibility requirement. I would like for people like Flipper or Henry to chime in or any other patent attorney who might be reading this.
So for those speculating about the massive capping at $1. This is NOT covering. It could be that one shorter is buying the shares another shorter is using to cap it, but it is 100% not a net covering going on. There's likely someone accumulating, but they are not the reason it is at $1, they are just taking advantage of it. Some of the selling could be traders as it has looked different that other days when they were capping. These traders are likely trying to move with the shorts and take advantage of their work. The only problem is that moves have been a lot more expensive without the help of MM's spoofing. Another problem for the shorts with the traders selling (which they need) is that these traders will also buy when price goes down and compete with the shorts trying to cover and move price back up too fast. It's all rather fascinating to watch as compared to before, when the downward moves happened with no real explanation at the time. We now know it was spoofing.
Volume at this time is 3.09M
2.092M at $1
343k at $0.9999
295k at $0.9998
so 2.73M of 3.09M sold at $1, that is 88% of shares sold. That's pretty telling about the capping going on.
They might just have been hoping the price was higher when they did the sale. We all should know that this was not an agreement done on 12/1. At least those of us who have been an insider in a publicly traded company.
Shorts and Market Makers might be hoping that the traders will expect them to close the gap and help with the move down to cover. Otherwise, I don't see that gap closed.
That's not quite true. The MHRA did allow the PIP trial design to be the same as the final SAP for DCVax-L phase III. That would not have happened if they had not felt that the trial design was acceptable for approval. You are somewhat right that we have yet to hear from other 3 RA's, though the FDA has signaled that ECA's is the way forward for these kind of trials.
I am sure they will try the afternoon bear raid. It all depends on how many shares they can find/buy to use. More MM's seem to have jumped in to help OTCN clients short/cap.
In other words: "If we can't spoof, we will just short it to keep the price down and show that the SP would not have been higher.....". I tend to agree, but the capping action is not bringing price down, so counter argument could be that in that case, it would just have stayed around $2 and not gone down. BUT I do think that is partially what is going on. I do think they are careful to not do too much naked/FTD shorting, as that could be discovered in the lawsuit. It's definitely still being manipulated, just more with shorts than MM trading.
IF this insider buy was scheduled months ago, but timed for AFTER the filing of the suit, which they likely have known about for quite some time, it would not preclude the chance of big news. The knowledge at the time of the purchase, if done some time ago, would probably be that they knew the JA would come in the near future, followed by the filing of the law suit. The purchase price of the C-shares looks like was based on the share price on Dec. 1.
I think the news of insider buying is great news. It lines up with my previous thoughts that a partnership this year is highly unlikely. If something like that was happening, Jerry would likely be bared from purchasing if he had any information about this. I do not think it is out of the question, just highly unlikely. NWBO is very top centric in the control of the company, so there's a slight chance that Jerry has not been part of nor has any direct knowledge about any negotiations, but this is unlikely. The deal for his purchase of the C-series shares COULD have been entered into at a much earlier date with the effective date being the day the suit was filed. That would be a way to not trade on insider information, but again unlikely. The poster who said that something has already been signed, might mean a CRL agreement or the MAA application or a BLA submission.
I agree that based on the June presentation, I would not completely eliminate the possibility that Flaskworks could be included. The time it has taken, also leads me to believe there's a chance. We are close to 4 weeks past the median time for MIA approval timeline. As we already had the GMP for the compassionate use manufacturing, I would have assume that the MIA would have been done on the shorter side of the 90 day average MIA cert. That being said, it is probably more likely it is not included.
Day their domain was set to expire, but was renewed last week. Sorry to disappoint.
Let them defend the SP at certain levels on the way up. The 1M shares used to defend at 0.92 are already down $120k. The more shares they use at every level, the more they have to cover when we really start moving on the next news. Unfortunately I see retail traders taking profits at these levels too, but can't blame anyone for taking 10% profit.
Not the first time we see a very friendly relationship between NWBO/Advent and AstraZeneca on social media.
If we can get some data from combo trial, it would be huge. Not sure the SP will be an honest reflection of how huge that would be, but it would solidify the chances of a partnership in 23 and could be big for approval timeline too. If the combo trial show significantly better results than Mucidencel by itself, it would be a great indicator for faster approval and move it to a 100% approval in my mind. I do think we are in the high 90's in term of chance for approval right now.
Won't see any partnership/JV news this year. IMHO. We will see some UK news with MIA and possible MAA application, which should give us a better timeline for UK/EU approval and likely US approval too
I don't necessarily disagree with that sentiment. I am pretty sure, however, that what happened to DNDN and the early problems NWBO faced in the market place, are the reason we have a heavy presence in the UK. LP 'gave' up the US manufacturing and focused on the UK manufacturing support, likely because she felt there would be a lot less resistance in the UK. I find it ironic that the first negative comment on JAMAOnc was from a few UK doctors who have serious conflict of interests, whether that be TTF or radiation conflicts.
Ex. I was asked why I was soft on him in a reply, but his reply included positive statement of the trial, so I wanted to say good on him for changing his tune.
Bio, you've got to relax. Your fear of getting people angry is baseless. You probably would never have filed the lawsuit, as it might anger the MM's.
There's no one saying that what happened to Dendreon will happen to NWBO. What I have said is that there's so many things that they had to deal with, which we have seen in the constant manipulation of both NWBO stock and DCVax-L/Murcidencel. There's so many things that LP have learned from DNDN mess too, that hugely benefit NWBO, such as manufacturing and using multiple RA's for approval. You don't think that these two issues are at the forefront of LP's tactics because of DNDN?
It's a fact that Pazdur was at the advisory panel meeting, without any reason AT ALL to be there. It is a fact that he was mentioned in emails that were obtained through the FOI act with Dr. Martin. It is a fact that these emails were between her and Dr. Scher and were about moving Provenge to another agency within the FDA for the approval decision. It is a fact that Dr. Martin went on to work for a Milken controlled company upon leaving the FDA,
He might have changed his tone due to a horrible event in his private life, but he was instrumental in the delay of approval for Provenge.
He was one of the main reasons Provenge was denied approval in 2007, according to Deep Captive. I hope, like others who were involved back then, he has turned a new leaf and that the many deaths he might have on his conscience (if he has one) has made him see the light. I sure hope that his viewpoints on ECA's are not only meant for easing the approval process for BP, but that he was aware of 'our' trial when his article was written.
I guess this is how you become more powerful in the FDA:
"For now, it merely needs to be emphasized that Pazdur, the FDA official, has unusually close
relationships with Milken and some of his cronies. He was a key player in the ImClone scandal, which
displays remarkable similarities (such as hedge funds in the Milken network betting with great prescience
and insider information mysteriously appearing in The Cancer Letter) to the Dendreon scandal. And with
the apparent encouragement of Dr. Scher and Alison Martin at the National Cancer Institute, Pazdur
appears to have played a key role in derailing Dendreon’s prostate cancer treatment.
Pazdur was not supposed to be the one who decided whether Dendreon’s drug was approved. Instead,
because the drug is a biologic, the decision rested with the FDA’s Center for Biologics Evaluation and
Research (CBER). Nonetheless, Pazdur inserted himself into the decision process. It was at Pazdur’s
behest that Dr. Scher and Dr. Hussain were, despite their ties to competing companies controlled by
Milken’s funds and friends, appointed to the advisory panel that voted on Dendreon’s application."
UK and EU RA's will be the key difference in regard to the final outcome for Murcidence, along with NWBO's focus on manufacturing. Linda Powers have definitely read the Provenge story and have used the shortfalls from Dendreon as the strengths for NWBO. The timing of the lawsuit is absolutely perfect.
I was always dubious about claims that LL was afraid on 5/10, as I have been told she actually did have Covid from a reliable UCLA source. Reading this story about Provenge, I can see how deeply AF could be involved with nefarious people that he would threaten her and making her decide not to do the presentation virtually from the UK. I am not saying this is the case, but I can see it possibly being true.
There's a huge difference between 2007 and 2022, which is one of the reasons I think NWBO will still be a successful investment, even after reading the story of Provenge.
SOCIAL MEDIA AND TECHNOLOGY.
Back then, people supporting Provenge had no way to access the public with the TRUE story, With the popularity of social media, these stories can now come to light and shame the actors involved. Technology has also made it easier to prove the bad acts of people, which should be evident from looking at the facts section of the lawsuit.
Please read the story I linked to. I am not talking about the science at all. Just the web surrounding the bears actions and methods of keeping this drug from saving lives. You might actually see versions of yourself in the story. LOL
I can see why they brought him on when they did. He will likely be a very prominent figure over the next 12 months as a link between NWBO and the DOJ. Without the DOJ or at least the prospects of the DOJ working with NWBO and their lawyers, the lawsuit would not be as damaging to the defendants.
You can find the same arguments in that story like:
"There are better treatments coming in the future". Our UK friends main argument
"The trial will never get approved by FDA" . Our good friends Ex, The Dr and Hygro
A letter written to the FDA by a panelist from their advisory panel, who neglected he had a conflict of interest, which was not true. Our other UK friend Matt Williams, who wrote the comment on the JAMA article.
I am not even referring to the naked short aspect of Dendreon stocks, as I am not convinced that it is the same. It could be now that they might need some naked shorts to keep the price down, but without the options market and with a chance of uplisting on the horizon, this might not be in their current arsenal. The legal shorts might actually wish for uplisting, so they can engage in a more widespread shorting.
There's hundreds of these similarities in this story.
Charities with deep conflict of interests, like the two charities mentioned in a previous post.
Simply an amazing story and a must read for EVERY investor in NWBO. My jaw is still dragging on the floor from the similarities. I wish I would have read this story years ago. I would still have been invested in NWBO, but I would have been trading the stock like crazy. Now with the new lawsuit, that trading part is likely gone.
Reading the story of Provenge is amazing. The arguments from bears are exactly the same as is going on with Murcidencel. If anyone has not yet read the story, I will say it is a must read. Yes it is long and can be a bit confusing because of the 100's of names and characters, but the gist of the story is amazing. Corrupt doctors, journalists and charities. How has this story not been made into a movie? Likely because the government failed to bring those involved to justice, so no real ending to feature. When you read the story, you will find the characters of the story and their arguments are similar to several 'people' you know.
https://www.sec.gov/comments/s7-08-09/s70809-4614.pdf
Thanks QL. What a fascinating story. I agree this is some of what has been going on with NWBO. Obviously some of the people trying to discredit the trial are HF plants. We know a few.
I am not an expert in anything that has to do with science. I have a question to those who know a lot more than me. Do you think that the Direct trial was put on hold because of the fact that NWBO and their scientific advisors thought that it could be approved relatively quick after approval of L, due to the 'platform' nature of the DC Vaccine? I understand that there was a monetary aspect of this as well, as trials are expensive and they decided to focus on L.
If the judge issues something to that effect, minus the limitations of where they can trade which would not be applicable in our case, I would be happy. It's obviously a completely different case, but the monitoring closely of the defendants trades in NWBO with all the tools available would be a good place to start. The added scrutiny can only benefit NWBO.
To begin with, I find it interesting that the shorts seemingly now only use OTCN as their tool to trade. They have probably decided not to use the 7 MM's named in the suit in order to avoid unnecessary oversight.
All your favorites!
Thank You Administrator who bailed me out.
I truly think that they would have left the MM's and their greed alone if May 10, 2022 had not happened. It could have been the straw that broke the camels back. At that time they knew they had great results and was waiting for the market to acknowledge these results. That makes me think that anything surrounding AF and his actions involved in and around May 10, 2022 could come out in the open soon. I would not be surprised to see his name being brought up as we get further along.
Also, I have always had such a hard time understanding shorty's play with keeping down the SP when shorting and if Shorty truly believes that NWBO is dead in the water. Why not let it run and then short at higher prices in order to have the opportunity to make more money. They have done that successfully a few times the last two years. I can think of only a couple of reasons. They know that it will not be possible for them to execute bear raids like they have in the past. They were relying on an assist from MM's in keeping the price in check and moving the price down. They probably feel now that they likely will not have that going forward. But why did they feel and act like 0.92 is their "Custer's Last Stand" and used a little over a million shares and close to $1M to keep the price at or below that level. I did also notice that they were also the big buyers at any price under 0.92 towards the end of the day and likely a few at 0.92 right at the end. Are they getting close to a price where they will receive the dreaded margin call? They could be. They are likely walking a fine line between selling and buying.
JMHO
Just a few observations.
We have been in a situation since yesterday, where shorts are working overtime to keep price down. I would imagine a few of the MM's are buying shares to lend out at higher levels. They are charging up to 17% for shorts to borrow the shares. Why would they have raised the cost of borrowing? Simply because they can. I understand that if you call your broker and ask what interest rate you can get, they will tell you a number in the single digits, but that is not the cost to the people wanting to borrow the shares. The fact that they are able to lend out shares at this rate, seems to suggest that these shorts are desperate, that they are getting close to being over leveraged and also that they are hoping the borrowing will be short term. You can see that using OTCN is the tool for the shorts. They have been the lowest ask for 99% of the time since yesterday. Every time they take a breather, the stock moves up. Let's see how much ammunition they have and how much they are willing to burn. It's definitely going to be an interesting afternoon.
The fact that the 7 MM's have been put on notice about their spoofing doesn't mean they won't trade in the stock. Their algo's are still working overtime to make money trading the stock. They will likely not assist the shorts in the bear raid as they have done previously.
In regard to yesterdays question about a Merck and NWBO deal, I want to make it clear that I don't think a deal has been signed. I think a framework of a deal has been made, depending on the success of the Merck sponsored combination trial result.
I spoke to two Apes yesterday and they said that they are working to get NWBO on the Apes radar. It will take time. As for the Robinhood problem, they seem to think the majority moved out of Robinhood after the GME debacle and are likely with bigger brokers now. They seemed really pleased by NWBO's lawsuit as they understand that it was the driver behind yesterday and todays upward movement in AMC. They also said that the whole Ape system is not as centralized as people might think and that NWBO interest would hopefully grow over time.
I hate to say it, but I am pleased we didn't get MIA news this week. We have been able to use the lawsuit and the support that have garnered to start the move. I hope we get the news Wed or Thur next week. That will give the lawsuit a little runway by itself and hopefully we will learn something from Dr. Liau's webinar on Monday. It will also get the Apes some time to get on the NWBO bandwagon, just in time for the MIA. I know this is wish thinking, but one always have the right to be hopeful.
Thanks for the support shown yesterday in regard to my 1 post limit. I had way too many violations, with most of them being off topic. I should have stopped linking to posts on other boards that implied the reason for posters on this board. For that I am guilty.
Enjoy the weekend.
"It's a beautiful day in Zamunda"!
It is nice to see management being proactive today and creating a runway for future news. I have read the lawsuit twice and as a law school graduate, I am very impressed with it. There's just enough mentioning of patients in there for anyone reading this to understand the third party implications of the acts that are being alleged.
I think it is nice to see the stock trade in a relatively normal fashion. Retail and traders buying and a few traders likely selling for pennies and Shorty trying to keep the price down. That's how the market should work. Adding 300BPS to the cost of borrowing also brings a smile to my face. Not sure when we will see a more realistic valuation of NWBO, but the lawsuit news should bring in more retail and traders as the news of it spreads throughout the next week or so. This is 'free' advertisement to a market that is sick and tired of MM's and HF's screwing the little guy and in our case the patients too. I think the trading in the next week or two will be volatile as the shorts will not give up easily. It will be a lot harder for them now that they don't have the cover of MM's to assist them in the bear raids. I sure hope that we see a change from the MM's and not just short term until the 'dust settles'.
I have a question in general for the board. I will not be able to respond to this as I am only allowed to post once a day due to my previous violations of the rules, for which I am extremely remorseful (should any administrator read this).:
Do any of you think that there's not already a deal done (or at least outlined based on the combination trial) with Merck? Do you think they are going to sponsor a trial with Murcidencel without any guarantees from NWBO that they will have access to Murcidencel if the trial is successful? Do you think they will sponsor a trial with the knowledge that BMY or any other company could come in and buy NWBO, leaving them without access to Murcidencel? I would think that they have at least gotten a guarantee from NWBO that they will have future access to Murcidencel, in one form or the other. It doesn't have to be an exclusive partnership guarantee or a buy out promise, but they would at least have gotten a non-exclusive right to use Murcidencel with Keytruda if trial is successful. JMHO
As I am writing this, I can see we have moved up 3 cents during my longwinded post, which is always a good sign.
See you all tomorrow. Enjoy the good news and have a nice glass of wine tonight. Let's hope the market the next few days look at this as favorable as I do.
While we wait for something to happen, it looks like the MM's have decided (for now) that we will stay in the 0.83-0.85 trading range. We might see a few attempts to break the lower end of that range, but we might also see an attempt to move it up. CDEL have been support and frankly I have no idea if they are buying to cover clients or to have shares to keep the upward momentum down. One thing is for sure, they have gobbled up a lot of shares, even at these low levels of volume.
I am still of the belief that we could see the MIA any day now and that this could spur a seldom seen PR from NWBO. As for the other rumors, I have not myself been able to find any support for them. I have a few friends who are desperately calling their friends to find any little bit of knowledge they can, and I will gladly share if/when I get some info that is not considered inside info.
I was pointed to NWBO by someone who had a long time working relationship with NWBO as a third party service provider. They put their working relationship on hold when the trial ended. That person was very certain to let me know that NWBO was a 'legacy' project for LP. How to use that information is up to each and every one. I take it to mean that she will be involved through approval and maybe even through commercialization process.
I will remain patient and watch the next few months play out. I am looking forward to the LL webinar on Monday, but only from a science perspective and with no expectations that anything she will reveal will have much influence on the short term SP. I do believe that she is now completely free to discuss a multitude of things we all want to know about, UNLESS she is in the process of writing another article for JAMA that has her embargoed about secondary endpoints and the combination trial.
I really don't know if we get any more info from NWBO, outside of a potential MIA cert acceptance prior to the definitive proxy or the ASM, but here's hoping.
Have a wonderful day.
Daily post.
I don't have much to add to the riveting conversation from today.
I do think that the C-shares could be used if an equity partnership was in the works, which I highly doubt at this time. There's very little likelihood that an equity partner would ever convert their 'Preferred' C-shares to common stock.
I definitely do not think that management is using the proxy vote as a way of doing an R/S 'without blame'.
I don't think 'the market' in general perceived the ASM PR as negative news. I think that today showed ample support and it will be interesting to see what happens the next few days. I think that some of the support today was from shorts covering, which is never good as they would have shares to short in the event the SP starts moving up.
For someone like me who have been skeptical about technicals, todays move down to close the 0.82 gap was interesting. The MM's do likely look at least a little to technicals, it seems like.
Finally, I was told that one of the rumors that has been churning around in the biotech financial world has been 'somewhat' confirmed!!! The only thing is that I have never been told what rumors were swirling and likewise has not been told which one has been 'somewhat' confirmed. My two biotech analyst 'friends' are a couple of bastards!!! LOL This last paragraph likely makes as little sense to you as it does to me, so I am not holding my breath. I will not believe anything until I see the actual information, so this is not a Pump. I actually was cutting and pasting this a few times before keeping it in the post. I am sorry if this leaves you more confused than before.
Enjoy the week and let's see where it goes.
A brief version today as it is Sunday and hanging out with my grandkids.
I am all for people voting their conscience. I hope people do take the time to understand what they are voting for as any vote has consequences. I am 100%!!! certain that NWBO will NOT go into bankruptcy if they do not get the vote to raise the authorized share count. I am also fairly certain that they are not bluffing when they mention that the alternative is an R/S. They would not have mentioned this if they were not serious about making sure that the AS number could cover their options/warrants obligations. I can't help thinking that this is due to something they are working on. They really didn't need this (which was why I thought they might hold the ASM without this proxy vote) as a majority of the warrants/options could be extended and they always had the 100M preferred share to use (among them 9M the c-shares). The mentioning of the R/S as the only viable option should this fail, makes me think this issue is important for them to get resolved in a timely manner for reasons I can only speculate about. I have never been adverse to an R/S if done right and for a company on a positive path, but I am still voting yes as that is the path selected by management who are privy to information that I am not. That being said, people should be entitled to vote their shares as they see fit.
Still a lot of rumors out there in biotech finance land, that my friends have not been able to verify, so for now, they remain just rumors for me. I think that we could see the MIA cert this week, as it likely is not state secrets as to when the inspection took place. I do not think we will get any news about a partnership in the next few days, but hope that some of the buzz around the combo trials will get us some news either December 5 or sooner.
Hope you enjoy what is left of the holiday weekend and that we see the market read the ASM news as a positive which I think it is. JMHO
Daily observations.
First off, I was wrong in MY OPINION that I didn't think they would raise the AS if they had an ASM this year. That was my own opinion and not a 'Campfire' story. My opinion was purely based on the preferred C-shares and nothing else, which I will talk about below.
In regard to the upcoming ASM, I will vote yes prop 6. I think it is the right thing to do as it is needed at this time. I know several shareholders with a lot more shares than myself and they are all voting to approve the raise in AS. I find it interesting that some of the posters who have been furiously against an R/S have stated they might vote no. That would be guaranteeing that we will see an R/S in the future. The company has even said so much: "the Company needs to either amend the Certificate of Incorporation to increase the number of authorized shares or implement a reverse split of the Common Stock." That could be scare tactics, but those who have read my previous posts, I do not see an R/S as negatively as others when done at the right time. I find it funny we have investors that do not understand the difference between authorized and issued and think the raise is a dilution.
I will also vote yes on the election of directors and likely on the ratification and approval of executive compensation.
In regard to the 500M raise in AS, I think that is a reasonable number. We currently have around a little less that 1.5B shares potentially issued when fully diluted (already issued plus options and warrant liablities). I am not including the 24M potential shares from the sold C-shares, as there's no saying if they would ever be converted. That gives them 200M shares of Common stock that is authorized but not issued. In addition they have the 100M preferred share to play around with, where 10M have been authorized as series C shares. Reviewing the document creating those shares, I saw that they were non-transferable EXCEPT when authorized by the board. I think that in the event of a partnership, they could use the C-shares as the shares to sell to the partner. I think that 10% would be a good percentage of the company for a partner to acquire. That would be just under 8M C-shares. A partner would not have any need to convert those shares to common stock and thus the c-shares would not impede in the 1.7B cap on common stock the company can issue. They would want to keep them as 'preferred' with all the benefits that entail versus common stock. The have the potential, currently, to issue up to 90M additional preferred shares as the articles of incorporation allows for 100M preferred shares in addition to the common stock shares. These could come in handy at a later time.
Personally, I think the ASM announcement is a positive. That is just my opinion. I do not have any idea how the market in general will perceive it. It seems like those fighting against NWBO use every news event to try to move the price lower. I do not know if they will do it this time, but they have proven that they can if they want to. I do think that with the JA out, they are either being careful or there's more support from the market in general. The daily SP is not a concern of mine, so this issue seems irrelevant at this time for me.
I am still not in the camp of a buy out will happen, now or in the near future. The raising of the AS from 1.2B to 1.7B does not in itself preclude it. It would actually be a sign that it was a possibility, due to the fact that after the raise, they will have enough shares to issue which is important in a BO/Merger. BUT the current SP is in my mind a close to 100% guarantee that it won't happen. LP is not selling NWBO at this or anywhere near this level.
I do think that a partnership would still be an option. I have mentioned how I would like to see such a partnership structure and to me that is still the best option. $x upfront. $x for milestones. Maybe $x for x amount of shares (maybe 10% of the company at a price either pre-determined or at a certain date) and a profit sharing for perpetuity (BMY paid NKTR 65% in their setup for exclusive rights for 9 indications). Merck is still my favorite, based on Duffy, the value it can bring to Keytruda and the fact that Keytruda seems to be the checkpoint inhibitor with the best results in most indications. That doesn't exclude others from being in the mix.
I think that at least one thing, if not more, will need to happen before any deal can be announced. We need to get the MIA for Sawston. That is almost a given, as any partner would want to know that commercial production of Murcidencel is in the clear before paying out money for a partnership. I think that could literally happen any day now.
We might also actually have to have the shares available (ASM and a yes vote for raising the AS). If the partner is Merck, they might be waiting for news from the combo trial. I remember that at this time last year, a few posters were hoping for some form of intermediate results. Now that the results of Murcidencel has been announced, it could free up the release of some new about the combo trial. As I am not a scientist, they might have to wait for approval of Murcidencel before they can release any news, but I don't know. I just know that people more involved with the science were hoping for some news last year.
Sorry for the longwinded post. JMHO. I am an easy target to argue with as I am not able to respond. Hope your Thanksgiving was amazing and that we see some positive signs in the near future.
Slightly shorter than normal daily observations. (sorry, I started rambling again, so became longer than anticipated)
No significant change in the legal outstanding shorts as of 11/15/22. Still slightly above 27M. Doesn't look like the shorts were expecting positive results by SNO.
Still quite a few rumors going on regarding a deal in the works. Not jumping on that wagon yet, but as previously mentioned, the BMY/NKTR deal setup seems perfect for all parties should a deal be in the works.
No news about MIA this week (so far), so hoping for next week, though I am not predicting, just hoping. Think this is a MUST have milestone prior to any deal.
I have been trying to think about how and what NWBO management could communicate at this time without saying much, but everything I have come up with would be information that likely should be avoided at this time, if they are working on something important behind the scene. I do wish, like all of you, that they start singing their song as this silence is deafening and hard on all of us, even me, who is not planning to sell for a long time (at least approval, but likely not until income starts rolling in).
I have never been much of a pro technicals for NWBO. It does, however, look like the traders and MM's do pay attention to the technicals and that they could be somewhat relevant at this time. I have always been thankful for our two Stallworth's of charts and appreciate they continuous efforts to show off their skills.
ASM! Never thought that this years ASM would have any proxies for raising the AS count. I would not think that they would have a vote IF they were considering an R/S with uplist, as I doubt they legally have to ask us. If they enter a partnership, that also seems unlikely for a vote as they are not changing the status of our shares. All in all, I highly doubt they will have a proxy if they do have an ASM this year. I, personally, do not see a need to hold one, but would likely attend if at a reasonable place to visit.
At least the short term longs who focus on daily SP, should have a nice weekend with the downward trend having stopped and they can enjoy a 5% up day.
Have a safe weekend